If you ever slip, our guide on what to do after a missed GLP-1 dose walks through each medications catch-up window
The use of GLP-1 receptor agonists is frequently associated with gastrointestinal adverse effects, particularly nausea, vomiting, diarrhea or constipation
These concerns highlight the necessity for ongoing treatment and monitoring during GLP-1 therapy to ensure sustainable weight loss while minimizing adverse outcomes, such as sarcopenia
NS: Formal analysis, Investigation, Writing review & editing, Writing original draft
Eligibility is always a licensed provider call and must be documented
Stepping down to 1 mg is the more conservative approach but may result in reduced appetite suppression